HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Fassnacht Selected Research

Paraganglioma (Paragangliomas)

2/2024Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial.
12/2023Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement.
11/2023Somatostatin Receptor-Directed PET/CT Can Differentiate Between Different Subtypes of Head and Neck Paragangliomas.
1/2023Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.
1/2023Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort.
1/2022Improved Diagnostic Accuracy of Clonidine Suppression Testing Using an Age-Related Cutoff for Plasma Normetanephrine.
1/2022Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma.
1/2022Preanalytical Considerations and Outpatient Versus Inpatient Tests of Plasma Metanephrines to Diagnose Pheochromocytoma.
1/2021Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine.
1/2021Plasma Metabolome Profiling for the Diagnosis of Catecholamine Producing Tumors.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Fassnacht Research Topics

Disease

120Neoplasms (Cancer)
03/2024 - 05/2003
104Adrenocortical Carcinoma
03/2024 - 01/2005
34Adenoma (Adenomas)
08/2023 - 01/2005
28Cushing Syndrome
07/2023 - 03/2010
24Pheochromocytoma
01/2024 - 07/2005
20Adrenocortical Adenoma (Disease, Conn's)
08/2023 - 01/2005
19Paraganglioma (Paragangliomas)
02/2024 - 01/2014
18Body Weight (Weight, Body)
03/2024 - 08/2006
18Neoplasm Metastasis (Metastasis)
02/2024 - 12/2005
14Hypertension (High Blood Pressure)
02/2024 - 04/2014
11Thyroid Neoplasms (Thyroid Cancer)
01/2023 - 07/2009
11Pituitary ACTH Hypersecretion
09/2022 - 01/2015
10Adrenal incidentaloma
10/2023 - 12/2011
8Adrenal Insufficiency (Adrenal Gland Hypofunction)
03/2024 - 03/2005
8Weight Loss (Weight Reduction)
03/2024 - 03/2013
8Adrenal Cortex Neoplasms (Adrenocortical Cancer)
01/2021 - 06/2006
7Obesity
03/2024 - 03/2013
7Pituitary Neoplasms (Pituitary Adenoma)
04/2021 - 10/2015
7Carcinoma (Carcinomatosis)
01/2021 - 12/2005
6Disease Progression
12/2023 - 06/2012
5Hyperaldosteronism (Conn Syndrome)
11/2023 - 12/2018
4Psychogenic Polydipsia
11/2023 - 05/2011
4Polyuria
11/2023 - 05/2011
4Type 2 Diabetes Mellitus (MODY)
07/2023 - 07/2005
4Lymphatic Metastasis
07/2022 - 02/2019
4Hyperplasia
05/2022 - 01/2005
4ACTH-Secreting Pituitary Adenoma
01/2019 - 10/2015
3Polydipsia
11/2023 - 05/2011
3Necrosis
01/2021 - 01/2011
3Carcinogenesis
12/2020 - 03/2012
3Fatigue
10/2019 - 04/2015
3Hyponatremia
11/2018 - 10/2014
3Heart Failure
03/2015 - 04/2014
2Insulin Resistance
03/2024 - 05/2011
2Hemorrhage
02/2024 - 10/2021
2Dyslipidemias (Dyslipidemia)
10/2023 - 01/2016
2Morbid Obesity
10/2023 - 03/2013

Drug/Important Bio-Agent (IBA)

43Hydrocortisone (Cortisol)FDA LinkGeneric
10/2023 - 01/2005
35Mitotane (Lysodren)FDA Link
03/2024 - 04/2005
26Hormones (Hormone)IBA
02/2024 - 04/2005
20SteroidsIBA
12/2023 - 06/2006
17Proteins (Proteins, Gene)FDA Link
02/2024 - 05/2003
15GlucocorticoidsIBA
03/2024 - 03/2005
14Adrenocorticotropic Hormone (ACTH)FDA Link
05/2023 - 03/2005
13Messenger RNA (mRNA)IBA
11/2021 - 07/2005
12Biomarkers (Surrogate Marker)IBA
03/2024 - 12/2011
12AldosteroneIBA
11/2023 - 01/2005
12CatecholaminesIBA
01/2022 - 03/2013
11Dexamethasone (Maxidex)FDA LinkGeneric
10/2023 - 01/2011
9NormetanephrineIBA
01/2023 - 03/2013
8MetanephrineIBA
01/2023 - 01/2014
7Chemokine ReceptorsIBA
02/2024 - 01/2017
6AntigensIBA
02/2024 - 08/2005
6DNA (Deoxyribonucleic Acid)IBA
08/2023 - 05/2015
6Phosphotransferases (Kinase)IBA
01/2022 - 07/2009
6EnzymesIBA
01/2022 - 05/2003
6Tyrosine Kinase InhibitorsIBA
10/2021 - 07/2009
6LipidsIBA
01/2021 - 12/2006
6Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2019 - 03/2014
53-methoxytyramine (methoxytyramine)IBA
01/2023 - 01/2014
5ParaffinIBA
04/2022 - 09/2009
5SodiumIBA
04/2021 - 05/2011
5CateninsIBA
01/2021 - 01/2011
5Ubiquitin-Specific ProteasesIBA
01/2021 - 10/2015
5Etoposide (VP 16)FDA LinkGeneric
01/2020 - 02/2010
5Cisplatin (Platino)FDA LinkGeneric
01/2020 - 02/2010
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 02/2010
4Sunitinib (Sutent)FDA Link
02/2024 - 01/2011
4Succinate Dehydrogenase (Fumarate Reductase)IBA
12/2023 - 02/2015
4AndrogensIBA
12/2022 - 06/2003
468Ga-pentixaforIBA
11/2022 - 01/2017
4PlatinumIBA
09/2022 - 09/2009
4Adrenergic Agents (Adrenergic Drugs)IBA
01/2022 - 04/2017
4iodophenyl metomidateIBA
12/2021 - 06/2008
3Arginine Vasopressin (Argipressin)IBA
11/2023 - 05/2011
3N 30IBA
11/2022 - 12/2015
3cabozantinibIBA
01/2022 - 01/2020
3Formaldehyde (Formol)FDA Link
01/2022 - 01/2017
3GemcitabineFDA Link
01/2022 - 06/2008
3Sorafenib (BAY 43-9006)FDA Link
10/2021 - 12/2015
3Epinephrine (Adrenaline)FDA LinkGeneric
10/2020 - 02/2015
3Transcription Factors (Transcription Factor)IBA
01/2019 - 01/2007
3ErbB Receptors (EGF Receptor)IBA
01/2019 - 12/2010
3Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
03/2015 - 02/2013
3Capsules (Microcapsules)IBA
11/2010 - 06/2006
2semaglutideIBA
03/2024 - 02/2024
2LigandsIBA
02/2024 - 07/2005
2Arginine (L-Arginine)FDA Link
11/2023 - 01/2019
2Somatostatin Receptors (Somatostatin Receptor)IBA
11/2023 - 10/2022
2Immune Checkpoint InhibitorsIBA
06/2023 - 11/2021

Therapy/Procedure

49Therapeutics
03/2024 - 10/2007
14Drug Therapy (Chemotherapy)
01/2023 - 03/2008
10Adrenalectomy
10/2023 - 12/2006
10Radiotherapy
01/2023 - 06/2006
9Bariatric Surgery
03/2024 - 03/2013
8Immunotherapy
06/2023 - 08/2005
7Precision Medicine
02/2024 - 01/2017
5Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2023 - 03/2013
4Lymph Node Excision (Lymph Node Dissection)
01/2022 - 02/2012
3Adjuvant Radiotherapy
09/2022 - 11/2006